Reports for EPTIFIBATIDE

Ingredient

EPTIFIBATIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
INTEGRILIN 0,75 mg/mL Solution Resolved 2017-03-14 2017-04-11 2210
INTEGRILIN 0.75MG SOLUTION Avoided shortage 2017-07-24 2017-08-14 16762
INTEGRILIN 0.75MG SOLUTION Resolved 2018-06-04 2018-07-14 51171
INTEGRILIN 0.75MG SOLUTION Resolved 2018-07-23 2018-08-17 56238
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Resolved 2017-03-13 2020-02-13 1691
INTEGRILIN 2MG SOLUTION Resolved 2017-05-08 2017-08-10 9382
INTEGRILIN 2MG SOLUTION Resolved 2018-06-04 2018-07-04 51168
INTEGRILIN 2MG SOLUTION Avoided shortage 2018-08-21 2018-09-24 58622
INTEGRILIN 2MG SOLUTION Resolved 2019-07-30 2019-09-26 90224
INTEGRILIN 2MG SOLUTION Resolved 2021-11-18 2022-03-23 149545

Showing 1 to 10 of 11

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
INTEGRILIN 0.75MG SOLUTION Discontinued 2022-03-01 2024-02-14 155790
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
INTEGRILIN 2MG SOLUTION Discontinued 2022-03-01 2024-02-14 155794
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027

Showing 1 to 6 of 6